secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zomedica Corp. (ZOMDF)
CIK:        0001684144
Form:       8-K
Filed at:   2022-07-11T23:59:59+00:00
Accession:  0001654954-22-009486
Event type: m_and_a
Sentiment:  positive
Materiality: 0.65
Item codes: 2.01, 3.02, 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zomedica closes acquisition of Revo Squared for $6M cash plus warrants, earn-outs up to $4M
--------------------------------------------------------------------------------

- Completed acquisition of Revo Squared on July 1, 2022 for $6M base cash, subject to working capital adjustments.
- Issued 10-year warrant to Revo Squared for 10M common shares at $0.2201 per share.
- Earn-out payments up to $4M: $2M each when Revo net sales exceed $5M and $10M in any calendar year through 2027.
- Revo's MicroView digital cytology platform automates slide preparation; manufacturing moving to Roswell, GA facility.
- Company expects to launch MicroView to veterinary market in 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1684144/000165495422009486/0001654954-22-009486-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1684144/000165495422009486/zom_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-22-009486

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer